Disability NDIS concept
Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Shares in Freedom Care Group (ASX:FCG) were down more than -3% on Wednesday after revealing the NDIS wants to revoke its licence. Freedom Care has hired lawyers in turn.

The company is, ultimately, dependent for cashflow on being a services provider under the national disability welfare program. (Despite being called a “scheme” to avoid using the word welfare, NDIS is clearly a welfare program.)

But there’s a problem with that. The NDIS Commission, which does what it sounds like, wrote to FCG on Monday to tell it the Commission had formed a view its registered NDIS status should be revoked, and that it ‘may’ make an order for permanent ban.

That would mean FCG would be unable to re-register for the scheme later down the line. The Commission’s decision comes as a controversial Bill Shorten-led cost cutting review of the entire welfare program rolls on.

Why exactly the NDIS Commission has moved to ban FCG’s registration status is unclear but the company did note one issue at the end of its announcement on Wednesday.

“As noted in [our last quarterly, FCG] has also been affected by a payment suspension from the NDIS, due to a protracted review of FCGPL’s support services claims,” Freedom Care wrote.

“[We have] been advised by the NDIS that an update of this review will be provided this week.”

A subsidiary of the same name processes the payments and FCG says that entity handles about 80% of cash generating activities.

Company Non-Exec Chair Zoran Grujic noted the company was subject to an NDIS audit in late October, though, under the welfare program, those audits are annual events for registered providers.

FCG last traded at 12.5cps.

Join the discussion: See what HotCopper users are saying about Freedom Care Group and be part of the conversations that move the markets.

fcg by the numbers
More From The Market Online
HotCopper Daily Market Trends Graphic

Friday’s HotCopper trends: Buru Energy, Invictus Energy, BPM Minerals and other daily topics

With more than 600k average monthly users on the HotCopper forums, each and every discussion can…

PYC Therapeutics doses first patient in OLE study supporting kidney disease candidate

PYC Therapeutics has dosed the first patient in a Part D open-label extension (OLE) of an…

Auravelle Metals commences gold discovery aircore program at Nuckulla Hill

Auravelle Metals has commenced testing new drill targets at the Nuckulla Hill gold project in South…

BPM Minerals granted Bonnie and Clyde drilling approvals

BPM Minerals has received the final key approval allowing for the maiden Bonnie & Clyde drilling…